Laurilee Kearnes - 06 Aug 2023 Form 4 Insider Report for HARTE HANKS INC (HHS)

Reporting relationship
Chief Financial Officer
Issuer ticker
HHS
Reported as of
06 Aug 2023
Net transaction value
-$65,339
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Aug 2023, 16:27:06 UTC
Prior SEC filing
26 May 2023
Next SEC filing
24 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Laurilee Kearnes

Key filing fact

Laurilee Kearnes filed Form 4 for HARTE HANKS INC (HHS) on 08 Aug 2023.

Key facts

  • This page summarizes Laurilee Kearnes's Form 4 filing for HARTE HANKS INC (HHS).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Aug 2023, 16:27.

Change

  • Previous filing in this sequence was filed on 26 May 2023.
  • Current net transaction value: -$65,339.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HHS transaction

Common Stock

Tax liability

Transaction value
$15,377
Shares
-2,624
Change %
-2.6%
Price
$5.86
Shares after
99,804
Date
06 Aug 2023
Ownership
Direct
Footnotes
F1
HHS transaction

Common Stock

Tax liability

Transaction value
$49,962
Shares
-8,526
Change %
-8.5%
Price
$5.86
Shares after
91,278
Date
08 Aug 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld to offset the reporting person's tax obligations upon vesting of the Restricted Stock Units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .